Abstract: The present invention is related to pyrazoline dione derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
September 27, 2010
Date of Patent:
July 19, 2016
Assignee:
GENKYOTEX SA
Inventors:
Patrick Page, Francesca Gaggini, Benoît Laleu
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
September 22, 2009
Date of Patent:
August 4, 2015
Assignee:
GENKYOTEX SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
January 4, 2013
Date of Patent:
July 7, 2015
Assignee:
GENKYOTEX SA
Inventors:
Patrick Page, Mike Orchard, Laetitia Fioraso-Cartier, Bianca Mottironi
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
January 31, 2013
Date of Patent:
April 21, 2015
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
January 31, 2013
Date of Patent:
April 14, 2015
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
July 5, 2013
Date of Patent:
January 27, 2015
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Abstract: The present invention is related to pyrazolo piperidine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
February 17, 2011
Date of Patent:
October 21, 2014
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Benoît Laleu, Francesca Gaggini, Mike Orchard
Abstract: The present invention is related to pyrazolo piperidine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
February 17, 2011
Date of Patent:
June 10, 2014
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Benoît Laleu, Francesca Gaggini, Mike Orchard
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
September 22, 2009
Date of Patent:
July 9, 2013
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
September 22, 2009
Date of Patent:
June 4, 2013
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
September 22, 2009
Date of Patent:
June 4, 2013
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
March 20, 2008
Date of Patent:
March 5, 2013
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Mike Orchard, Laetitia Fioraso-Cartier, Bianca Mottironi
Abstract: The present invention is related to pyrazolo piperidine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Application
Filed:
February 17, 2011
Publication date:
December 13, 2012
Applicant:
GENKYOTEX SA
Inventors:
Patrick Page, Benoît Laleu, Francesca Gaggini, Mike Orchard
Abstract: The present invention is related to pyrazolo piperidine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Application
Filed:
February 17, 2011
Publication date:
December 13, 2012
Applicant:
GENKYOTEX SA
Inventors:
Patrick Page, Benoît Laleu, Francesca Gaggini, Mike Orchard
Abstract: The present invention is related to tetrahydroindole derivatives of Formula (I), pharmaceutical composition thereof, methods of preparation thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
March 28, 2008
Date of Patent:
October 16, 2012
Assignee:
Genkyotex SA
Inventors:
Patrick Page, Mike Orchard, Laetitia Fioraso-Cartier, Bianca Mottironi
Abstract: The present invention is related to pyrazoline dione derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Application
Filed:
September 27, 2010
Publication date:
July 5, 2012
Applicant:
GENKYOTEX SA
Inventors:
Patrick Page, Francesca Gaggini, Benoît Laleu
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Application
Filed:
September 22, 2009
Publication date:
November 3, 2011
Applicant:
GENKYOTEX SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini